| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $125.6B | $122.3B | $32.0B | $31.3B | $168.9B | $171.8B | $46.8B | $48.0B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $28.9B | $28.4B | $28.9B | $29.0B | $37.9B | $38.0B | $39.4B | $36.8B |
| Operating Income | $24.2B | $19.0B | $5.3B | $-21.1B | $23.3B | $6.4B | $5.3B | $6.2B |
| Net Income | $22.0B | $10.9B | $14.4B | $-8.5B | $20.1B | $-5.2B | $2.4B | $4.9B |
| EPS (Basic) | $3.04 | $1.49 | $1.97 | $-1.13 | $2.77 | $-0.75 | $0.33 | $0.66 |
| EPS (Diluted) | $3.04 | $1.49 | $1.97 | $-1.13 | $2.76 | $-0.75 | $0.33 | $0.66 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $420.2B | $394.8B | $407.1B | $402.9B | $551.6B | $525.8B | $551.7B | $531.9B |
| Current Assets | $48.7B | $31.2B | $36.5B | $33.1B | $60.0B | $52.0B | $54.8B | $51.4B |
| Cash & Equivalents | $18.2B | $3.3B | $6.7B | $3.7B | $21.2B | $9.7B | $12.1B | $5.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $53.8B | $46.9B | $51.1B | $56.2B | $85.6B | $63.4B | $68.9B | $64.4B |
| Stockholders' Equity | — | — | — | — | — | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $40.3B | — | — | — | $42.0B | $43.1B | $48.7B | $43.6B |
| Investing Cash Flow | $-18.8B | — | — | — | $-32.1B | $-13.5B | $-16.7B | $-63.1B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-6.4B | — | — | — | $1.6B | $-32.0B | $-25.1B | $-26.0B |